$AMED
AMEDISYS INC

2019 Q4 Form 10-Q Financial Statement

#000089626219000014 Filed on October 30, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $500.7M $494.6M $417.3M
YoY Change 15.26% 18.52% 11.67%
Cost Of Revenue $295.6M $288.7M $249.7M
YoY Change 12.7% 15.62% 9.87%
Gross Profit $205.1M $205.9M $167.6M
YoY Change 19.17% 22.85% 14.48%
Gross Profit Margin 40.96% 41.63% 40.16%
Selling, General & Admin $156.1M $154.7M $124.5M
YoY Change 17.99% 24.26% 4.71%
% of Gross Profit 76.11% 75.13% 74.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.000M $4.300M $3.200M
YoY Change 76.47% 34.38% -21.95%
% of Gross Profit 2.93% 2.09% 1.91%
Operating Expenses $162.0M $159.1M $127.7M
YoY Change 19.38% 24.59% 3.82%
Operating Profit $43.10M $46.80M $39.90M
YoY Change 18.41% 17.29% 70.71%
Interest Expense -$1.800M $3.778M $1.991M
YoY Change 500.0% 89.75% 49.14%
% of Operating Profit -4.18% 8.07% 4.99%
Other Income/Expense, Net -$400.0K -$2.600M $1.485M
YoY Change -126.67% -275.08% 127.76%
Pretax Income $39.40M $44.24M $41.37M
YoY Change 7.65% 6.94% 72.21%
Income Tax $11.40M $9.919M $9.825M
% Of Pretax Income 28.93% 22.42% 23.75%
Net Earnings $27.70M $34.10M $31.40M
YoY Change 0.73% 8.6% 115.07%
Net Earnings / Revenue 5.53% 6.89% 7.52%
Basic Earnings Per Share $0.86 $1.06 $0.99
Diluted Earnings Per Share $0.83 $1.03 $0.96
COMMON SHARES
Basic Shares Outstanding 32.26M shares 32.21M shares 31.82M shares
Diluted Shares Outstanding 33.00M shares 32.69M shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.30M $20.80M $14.00M
YoY Change 50.0% 48.57% -78.82%
Cash & Equivalents $30.30M $20.76M $14.01M
Short-Term Investments
Other Short-Term Assets $8.200M $13.46M $11.95M
YoY Change 12.33% 12.63% -51.62%
Inventory
Prepaid Expenses $8.243M $10.60M $11.68M
Receivables $237.6M $254.7M $195.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $350.6M $299.5M $232.7M
YoY Change 56.41% 28.73% -13.25%
LONG-TERM ASSETS
Property, Plant & Equipment $28.10M $29.97M $30.22M
YoY Change -4.42% -0.81% -7.6%
Goodwill $658.5M $660.5M $324.1M
YoY Change 99.85% 103.76%
Intangibles $64.70M $66.47M $44.31M
YoY Change 46.71% 50.01%
Long-Term Investments
YoY Change
Other Assets $54.60M $54.26M $53.41M
YoY Change 0.92% 1.6% -61.88%
Total Long-Term Assets $912.2M $912.9M $493.2M
YoY Change 85.03% 85.08% -7.17%
TOTAL ASSETS
Total Short-Term Assets $350.6M $299.5M $232.7M
Total Long-Term Assets $912.2M $912.9M $493.2M
Total Assets $1.263B $1.212B $725.9M
YoY Change 76.09% 67.02% -9.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.26M $35.90M $24.52M
YoY Change 9.56% 46.42% 7.47%
Accrued Expenses $137.1M $127.1M $101.2M
YoY Change 37.79% 25.63% 21.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.900M $9.000M $1.200M
YoY Change 518.75% 650.0% -87.23%
Total Short-Term Liabilities $326.9M $314.7M $219.3M
YoY Change 46.96% 43.49% 8.61%
LONG-TERM LIABILITIES
Long-Term Debt $232.3M $231.6M $54.90M
YoY Change 3905.17% 321.86% -31.8%
Other Long-Term Liabilities $5.900M $6.002M $6.253M
YoY Change -4.84% -4.01% 60.33%
Total Long-Term Liabilities $238.2M $237.6M $61.15M
YoY Change 1885.0% 288.54% -24.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $326.9M $314.7M $219.3M
Total Long-Term Liabilities $238.2M $237.6M $61.15M
Total Liabilities $621.2M $608.9M $280.4M
YoY Change 164.93% 117.16% -2.07%
SHAREHOLDERS EQUITY
Retained Earnings $246.4M $218.7M $92.09M
YoY Change 106.09% 137.52%
Common Stock $645.3M $634.9M $592.5M
YoY Change 6.89% 7.14% 5.55%
Preferred Stock
YoY Change
Treasury Stock (at cost) $251.2M $251.1M $240.5M
YoY Change 3.95% 4.38% 351.9%
Treasury Stock Shares 4.354M shares 4.353M shares 4.269M shares
Shareholders Equity $640.5M $602.6M $444.1M
YoY Change
Total Liabilities & Shareholders Equity $1.263B $1.212B $725.9M
YoY Change 76.09% 67.02% -9.21%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income $27.70M $34.10M $31.40M
YoY Change 0.73% 8.6% 115.07%
Depreciation, Depletion And Amortization $6.000M $4.300M $3.200M
YoY Change 76.47% 34.38% -21.95%
Cash From Operating Activities $75.20M $47.50M $68.50M
YoY Change 17.5% -30.66% 571.57%
INVESTING ACTIVITIES
Capital Expenditures -$1.600M -$3.600M -$4.100M
YoY Change 77.78% -12.2% 141.18%
Acquisitions
YoY Change
Other Investing Activities $100.0K $100.0K -$3.300M
YoY Change -101.15% -103.03% -1750.0%
Cash From Investing Activities -$1.300M -$3.600M -$7.400M
YoY Change -86.46% -51.35% 393.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.900M -37.00M -73.00M
YoY Change -103.94% -49.32% 3955.56%
NET CHANGE
Cash From Operating Activities 75.20M 47.50M 68.50M
Cash From Investing Activities -1.300M -3.600M -7.400M
Cash From Financing Activities 1.900M -37.00M -73.00M
Net Change In Cash 75.80M 6.900M -11.90M
YoY Change 1122.58% -157.98% -272.46%
FREE CASH FLOW
Cash From Operating Activities $75.20M $47.50M $68.50M
Capital Expenditures -$1.600M -$3.600M -$4.100M
Free Cash Flow $76.80M $51.10M $72.60M
YoY Change 18.34% -29.61% 510.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
amed Episode Of Care As Episodic Based Revenue Duration
EpisodeOfCareAsEpisodicBasedRevenueDuration
P60D
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 visit
amed Net Service Revenue Episode Payment Rate Duration
NetServiceRevenueEpisodePaymentRateDuration
P60D
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 visit
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 visit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0000896262
dei Entity Registrant Name
EntityRegistrantName
AMEDISYS INC
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
95472000 USD
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
101446000 USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36252280 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36599273 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31973505 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32246575 shares
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33050000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
36799000 USD
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
1455000000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4278775 shares
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4352698 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-24260
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3131700
dei Entity Address Address Line1
EntityAddressAddressLine1
3854 American Way
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
Baton Rouge
dei Entity Address State Or Province
EntityAddressStateOrProvince
LA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
70816
dei City Area Code
CityAreaCode
225
dei Local Phone Number
LocalPhoneNumber
292-2031
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
AMED
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32255257 shares
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20757000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20229000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
254703000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
188972000 USD
CY2019Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10601000 USD
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7568000 USD
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
13458000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7349000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
299519000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
224118000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29969000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29449000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
84124000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q3 us-gaap Goodwill
Goodwill
660472000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
329480000 USD
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
66468000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
44132000 USD
CY2019Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
17568000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
35794000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54260000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54145000 USD
CY2019Q3 us-gaap Assets
Assets
1212380000 USD
CY2018Q4 us-gaap Assets
Assets
717118000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
35901000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
28531000 USD
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
115899000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
92858000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
127111000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
99475000 USD
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
8959000 USD
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1612000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26783000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
314653000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
222476000 USD
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
231641000 USD
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5775000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56619000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6002000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6234000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
608915000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
234485000 USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2018Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2019Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
37000 USD
CY2018Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
36000 USD
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
634854000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
603666000 USD
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
251070000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
241685000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
218728000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
119550000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
602564000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
481582000 USD
CY2019Q3 us-gaap Minority Interest
MinorityInterest
901000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
1051000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
603465000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
482633000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1212380000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
717118000 USD
CY2019Q3 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
494631000 USD
CY2018Q3 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
417335000 USD
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
1228200000 USD
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
1454955000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
288708000 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
249739000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
854734000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
730612000 USD
CY2019Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
99941000 USD
CY2018Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
79367000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
293127000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
232213000 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
6298000 USD
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
4842000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18451000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12653000 USD
CY2019Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
48474000 USD
CY2018Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
40335000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
140284000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
124119000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4366000 USD
CY2018Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3164000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12440000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9882000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
447787000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
377447000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1319036000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1109479000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
46844000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
39888000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
135919000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
118721000 USD
CY2019Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
15000 USD
CY2018Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
29000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
59000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
263000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
3778000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
1991000 USD
us-gaap Interest Expense
InterestExpense
11459000 USD
us-gaap Interest Expense
InterestExpense
5834000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-812000 USD
CY2018Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1625000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4120000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6461000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1975000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
131043000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44244000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31105000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41373000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29984000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
34325000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2782000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2600000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1485000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4876000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3672000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
122393000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9919000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9825000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1822000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2404000 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
31548000 USD
us-gaap Profit Loss
ProfitLoss
99938000 USD
us-gaap Profit Loss
ProfitLoss
92409000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
193000 USD
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
171000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
760000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
524000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
34132000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
31377000 USD
us-gaap Net Income Loss
NetIncomeLoss
99178000 USD
us-gaap Net Income Loss
NetIncomeLoss
91885000 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.78
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32211000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31815000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32096000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33075000 shares
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.71
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33002000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32691000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32944000 shares
CY2018Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
630000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
34325000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
603465000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
409061000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33852000 shares
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
562942000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
850000 USD
CY2019Q3 amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
2353000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2045000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6298000 USD
CY2019Q3 amed Surrendered Shares
SurrenderedShares
4895000 USD
CY2019Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
453000 USD
CY2018Q3 amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
2404000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
140000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4842000 USD
CY2018Q3 amed Surrendered Shares
SurrenderedShares
2589000 USD
CY2018Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
180000 USD
CY2018Q3 amed Equity Impactof Repurchaseof Noncontrolling Interest
EquityImpactofRepurchaseofNoncontrollingInterest
361000 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
31548000 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
445495000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
482633000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2384000 USD
amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
6966000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3388000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18451000 USD
amed Surrendered Shares
SurrenderedShares
9385000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
910000 USD
us-gaap Profit Loss
ProfitLoss
99938000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
603465000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
516426000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1787000 USD
amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
7185000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2749000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12653000 USD
amed Surrendered Shares
SurrenderedShares
5421000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
181402000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
530000 USD
amed Equity Impactof Repurchaseof Noncontrolling Interest
EquityImpactofRepurchaseofNoncontrollingInterest
361000 USD
us-gaap Profit Loss
ProfitLoss
92409000 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
445495000 USD
us-gaap Profit Loss
ProfitLoss
99938000 USD
us-gaap Profit Loss
ProfitLoss
92409000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12440000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9882000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18451000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12653000 USD
us-gaap Pension Expense
PensionExpense
7545000 USD
us-gaap Pension Expense
PensionExpense
6934000 USD
amed Amortizationand Impairmentof Operating Lease Right Of Use Asset
AmortizationandImpairmentofOperatingLeaseRightOfUseAsset
27014000 USD
amed Amortizationand Impairmentof Operating Lease Right Of Use Asset
AmortizationandImpairmentofOperatingLeaseRightOfUseAsset
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-738000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17798000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14916000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4120000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6461000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
653000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
596000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3727000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4373000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39469000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6166000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10194000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
32000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-202000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-726000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8145000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-670000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
27903000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14758000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-231000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2462000 USD
amed Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-24116000 USD
amed Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 USD
amed Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-2622000 USD
amed Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
126780000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
159450000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
287000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
51000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
210000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3477000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6337000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
563000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
158000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
70000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3820000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
192500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
225310000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-219182000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
127500000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
133000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5684000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
345460000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4074000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-351562000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12621000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3388000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2749000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2384000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1787000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9385000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5421000 USD
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
910000 USD
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
530000 USD
amed Proceeds From Borrowings Under Term Loan
ProceedsFromBorrowingsUnderTermLoan
175000000 USD
amed Proceeds From Borrowings Under Term Loan
ProceedsFromBorrowingsUnderTermLoan
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
91071000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
847000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2433000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
181402000 USD
amed Payments For Repurchase Of Noncontrolling Interest
PaymentsForRepurchaseOfNoncontrollingInterest
0 USD
amed Payments For Repurchase Of Noncontrolling Interest
PaymentsForRepurchaseOfNoncontrollingInterest
361000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
528000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-72353000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20229000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86363000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20757000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14010000 USD
us-gaap Interest Paid Net
InterestPaidNet
7756000 USD
us-gaap Interest Paid Net
InterestPaidNet
2989000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17656000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11017000 USD
CY2019Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
38 state
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99
us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our accounting and reporting policies conform with U.S. GAAP. In preparing the unaudited condensed consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2019Q3 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.50
CY2019Q3 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.50
CY2019Q3 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
35400000 USD
CY2018Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
35100000 USD
CY2019Q3 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.20
CY2019Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3700000 USD
CY2019Q3 amed Revenuebypayorclassasapercentageoftotalnetservicerevenue
Revenuebypayorclassasapercentageoftotalnetservicerevenue
1
CY2018Q3 amed Revenuebypayorclassasapercentageoftotalnetservicerevenue
Revenuebypayorclassasapercentageoftotalnetservicerevenue
1
amed Revenuebypayorclassasapercentageoftotalnetservicerevenue
Revenuebypayorclassasapercentageoftotalnetservicerevenue
1
amed Revenuebypayorclassasapercentageoftotalnetservicerevenue
Revenuebypayorclassasapercentageoftotalnetservicerevenue
1
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.10
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
4 visit
CY2019Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99
CY2018Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.97
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.10
CY2019Q3 amed Accounts Receivable Portion Derived From Medicare
AccountsReceivablePortionDerivedFromMedicare
0.59
CY2018Q4 amed Accounts Receivable Portion Derived From Medicare
AccountsReceivablePortionDerivedFromMedicare
0.56
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.60
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.50
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120 day
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60 day
CY2018Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3500000 USD
CY2019Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
200000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
600000 USD
CY2019Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3700000 USD
amed Unamortized Debt Issuance Cost Amortization Period
UnamortizedDebtIssuanceCostAmortizationPeriod
P4Y3M18D
CY2019Q3 amed Debt Instrument Carrying Amount Excluding Capital Leases
DebtInstrumentCarryingAmountExcludingCapitalLeases
240600000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32211000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31815000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32096000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33075000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
532000 shares
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
561000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
543000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
464000 shares
CY2019Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
259000 shares
CY2018Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
315000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
305000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
313000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33002000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32691000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32944000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33852000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
133000 shares
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
154000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
76000 shares
CY2019Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P9Y
CY2019Q3 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P3Y
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
8800000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
26000000.0 USD
CY2019Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
700000 USD
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
1000000.0 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
9500000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
27000000.0 USD
CY2019Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
500000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1300000 USD
CY2019Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
100000 USD
CY2019Q3 amed Finance Lease Cost
FinanceLeaseCost
500000 USD
amed Finance Lease Cost
FinanceLeaseCost
1400000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
700000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
1900000 USD
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
200000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
10800000 USD
us-gaap Lease Cost
LeaseCost
30500000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
84100000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26800000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56600000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
83400000 USD
CY2019Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5100000 USD
CY2019Q3 amed Lessee Financeleases Accumulated Amortization
LesseeFinanceleasesAccumulatedAmortization
1400000 USD
CY2019Q3 amed Financelease Rightof Use Asset Net
FinanceleaseRightofUseAssetNet
3700000 USD
CY2019Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1700000 USD
CY2019Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2000000.0 USD
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
3700000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
26700000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1200000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
106900000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
2700000 USD
amed Lessee Operatinglease Reductionsto Ro Uassetsresultingfromreductionstoleaseobligations
LesseeOperatingleaseReductionstoROUassetsresultingfromreductionstoleaseobligations
1200000 USD
amed Lessee Financelease Reductionto Ro Uassetsresultingfromreductionstoleaseobligations
LesseeFinanceleaseReductiontoROUassetsresultingfromreductionstoleaseobligations
0 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2019Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040
CY2019Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.053
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6300000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
500000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
29800000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1800000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
22100000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1400000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13100000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
200000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8200000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
11000000.0 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
90500000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
3900000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7100000 USD
CY2019Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
200000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
83400000 USD
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
3700000 USD
CY2019Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
244300000 USD
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10900000 USD
CY2019Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3700000 USD
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3500000 USD
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
240600000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
7400000 USD
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
9000000.0 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1600000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
231600000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5800000 USD
CY2019Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
725000000.0 USD
CY2019Q3 amed Total Leverage Ratio
TotalLeverageRatio
1.0
CY2019Q3 amed Consolidated Interest Coverage Ratio
ConsolidatedInterestCoverageRatio
19.5
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
1300000 USD
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
1000000.0 USD
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segments
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
377400000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
39900000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
854700000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
451900000 USD
CY2019Q3 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
494600000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
288700000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
154700000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4400000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
447800000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
46800000 USD
CY2018Q3 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
417300000 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
249700000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
124500000 USD
CY2018Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3200000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12400000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1319000000.0 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
135900000 USD
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
1228200000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
730600000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
369000000.0 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9900000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1109500000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
118700000 USD
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 USD
CY2019Q1 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2020-03-01

Files In Submission

Name View Source Status
0000896262-19-000014-index-headers.html Edgar Link pending
0000896262-19-000014-index.html Edgar Link pending
0000896262-19-000014.txt Edgar Link pending
0000896262-19-000014-xbrl.zip Edgar Link pending
amed-20190930.xsd Edgar Link pending
amed-20190930_cal.xml Edgar Link unprocessable
amed-20190930_def.xml Edgar Link unprocessable
amed-20190930_lab.xml Edgar Link unprocessable
amed-20190930_pre.xml Edgar Link unprocessable
amed-20193009x10xq.htm Edgar Link pending
amed-20193009x10xq_htm.xml Edgar Link completed
amed-20193009xexx101.htm Edgar Link pending
amed-20193009xexx311.htm Edgar Link pending
amed-20193009xexx312.htm Edgar Link pending
amed-20193009xexx32.htm Edgar Link pending
amed-20193009xexx321.htm Edgar Link pending
amed-20193009xexx322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending